Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -8.99% is 69% above its 5-year average of -28.89%, near the high end of its 5-year range (-67.27%–-0.81%).
77.84% below its 12-month average of -5.06%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -2.07%.
RETURN ON ASSETS (ROA)
-8.99%
RETURN ON ASSETS (ROA) AVG TTM
-5.06%
RETURN ON ASSETS (ROA) AVG 3Y
-16.59%
RETURN ON ASSETS (ROA) AVG 5Y
-28.89%
RETURN ON ASSETS (ROA) AVG 10Y
-35.98%
RETURN ON ASSETS (ROA) AVG 15Y
-41.74%
RETURN ON ASSETS (ROA) AVG 20Y
-31.55%
CURRENT VS TTM AVG
-77.84%
CURRENT VS 3Y AVG
+45.79%
CURRENT VS 5Y AVG
+68.88%
CURRENT VS 10Y AVG
+75.02%
CURRENT VS 15Y AVG
+78.46%
CURRENT VS 20Y AVG
+71.51%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+72.14%
vs the sector median at left
Rockwell Medical, Inc.
Market Cap
$30.19M
Return on Assets (ROA)
-8.99%
TTM Avg
-5.06%
3Y Avg
-16.59%
5Y Avg
-28.89%
Market Cap
$30.44M
Return on Assets (ROA)
-13.65%
TTM Avg
-19.04%
3Y Avg
-14.35%
5Y Avg
-23.11%
Market Cap
$29.91M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$29.74M
Return on Assets (ROA)
-49.53%
TTM Avg
-17.16%
3Y Avg
-133.18%
5Y Avg
-213.67%
Market Cap
$30.81M
Return on Assets (ROA)
-22.66%
TTM Avg
-23.43%
3Y Avg
-29.30%
5Y Avg
-40.97%
Market Cap
$29.57M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$30.92M
Return on Assets (ROA)
-116.76%
TTM Avg
-76.53%
3Y Avg
-78.60%
5Y Avg
-71.54%
Market Cap
$29.37M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
Market Cap
$31.11M
Return on Assets (ROA)
-11.09%
TTM Avg
-5.71%
3Y Avg
-4.17%
5Y Avg
-3.19%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | $30.19M | -8.99% | -5.06% | -16.59% | -28.89% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | -13.65% | -19.04% | -14.35% | -23.11% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | -115.56% | -181.38% | -357.07% | -299.51% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -49.53% | -17.16% | -133.18% | -213.67% |
| MDxHealth S.A. (MDXH)vs › | $30.81M | -22.66% | -23.43% | -29.30% | -40.97% |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -99.62% | -39.99% | -67.06% | 188.84% |
| CervoMed Inc. (CRVO)vs › | $30.92M | -116.76% | -76.53% | -78.60% | -71.54% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -102.56% | -232.33% | -191.42% | -176.42% |
| Accuray Incorporated (ARAY)vs › | $31.11M | -11.09% | -5.71% | -4.17% | -3.19% |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 1.29% | -1.07% | 2.48% | 2.98% |
ROA
-9.0%
ROE
-14.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -9.30% |
| 2024-12-31 | -0.81% |
| 2023-12-31 | -16.18% |
| 2022-12-31 | -40.05% |
| 2021-12-31 | -67.27% |
| 2020-12-31 | -39.73% |
| 2019-12-31 | -77.01% |
| 2018-12-31 | -61.12% |
| 2017-12-31 | -44.10% |
| 2016-12-31 | -23.81% |
| 2015-12-31 | -16.42% |
| 2014-12-31 | -21.76% |
| 2013-12-31 | -134.16% |
| 2012-12-31 | -317.31% |
| 2011-12-31 | -67.14% |
| 2010-12-31 | -7.26% |
| 2009-12-31 | -15.77% |
| 2008-12-31 | -41.48% |
| 2007-12-31 | -16.31% |
| 2006-12-31 | -34.78% |
| 2005-12-31 | 0.83% |
| 2004-12-31 | 2.75% |
| 2003-12-31 | 0.07% |
| 2002-12-31 | -15.20% |
| 2001-12-31 | -26.07% |
| 2000-12-31 | -25.09% |
| 1999-12-31 | -24.44% |
| 1998-12-31 | -35.85% |
| 1997-12-31 | -52.78% |
